文献速递血栓与止血

儿童药物性血栓预防的临床实践方法

How I approach pharmacological thromboprophylaxis in children.
PubMed 文献 · Blood · 2025-01-01

儿童静脉血栓栓塞症发病率持续上升,美国儿童医院信息系统数据库分析显示过去20年儿童住院相关静脉血栓栓塞症诊断增加200倍。儿童血栓预防指南除COVID-19住院儿童外尚缺乏。本文通过模型病例展示常见住院临床场景,综述静脉血栓栓塞症风险模型和药物性血栓预防临床试验证据,提出基于风险分层的实用方法,并指出未来儿科试验的关键知识缺口。

要点

  • 儿童住院相关静脉血栓栓塞症诊断过去20年增加200倍。
  • 除COVID-19住院儿童外,儿童血栓预防指南目前尚缺乏。
  • 药物性血栓预防应基于静脉血栓栓塞症和临床相关出血风险进行风险分层。

核心结论

  • 儿童药物性血栓预防应采用基于静脉血栓栓塞症和临床相关出血风险分层的实用方法,并针对不同亚人群和临床场景制定特异性策略。

研究设计与样本

  • 本文为综述,通过模型病例展示常见住院临床场景,综述静脉血栓栓塞症风险模型和药物性血栓预防临床试验证据。

主要发现

  • 美国儿童医院信息系统数据库最新分析报告过去20年儿童住院相关静脉血栓栓塞症诊断增加200倍。
  • 过去十年已发表多个儿童静脉血栓栓塞症风险预测模型,部分源自多机构数据。
  • 已开展针对特定儿科亚人群的血栓栓塞预防多中心随机临床试验。

临床怎么用

  • 作者提出针对不同临床场景的循证、亚人群和场景特异性药物性血栓预防方法。
  • 除COVID-19住院儿童外,目前尚缺乏针对多个不同高危亚人群和场景的儿童血栓预防指南。

局限性

  • 除COVID-19住院儿童外,目前尚缺乏针对多个不同高危亚人群和场景的儿童血栓预防指南。
  • 作者指出未来儿科试验需解决关键知识缺口以指导儿童血栓预防。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The incidence of venous thromboembolism in children continues to rise, with the most recent analysis from the Pediatric Hospital Information Systems database in the United States reporting a 200-fold increase in pediatric hospitalization-related venous thromboembolism diagnoses over the past 2 decades. In the past decade, several pediatric venous thromboembolism risk prediction models have been published, in some cases derived from multi-institutional data, and multicenter randomized clinical trials of thromboembolism prevention in specific pediatric subpopulations have been conducted. Yet, apart from children hospitalized for COVID-19, guidelines for thromboprophylaxis (TP) in children that address several distinct at-risk subpopulations and settings for venous thromboembolism are presently lacking. It is becoming increasingly apparent that approaches to pharmacological TP for hospitalized children should be risk-stratified regarding a priori risks of both venous thromboembolism and clinically relevant bleeding. In this manuscript, we present model cases of common inpatient clinical scenarios and review the evidence related to venous thromboembolism risk models and pharmacological TP clinical trials in children, describing a pragmatic approach to pharmacological TP for each scenario. We then conclude by describing our evidence-informed, subpopulation- and setting-specific approach to pharmacological TP for the clinical scenarios and reviewing critical knowledge gaps well-suited for future pediatric trials to inform TP in children.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Sochet AA, Kiskaddon A, Goldenberg NA, et al. How I approach pharmacological thromboprophylaxis in children. Blood. 2025. PMID: 39899879. doi:10.1182/blood.2024026327

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。